Cargando…

Comparison of Homologous Recombination Repair Gene Next-Generation Sequencing Analysis in Patients With Metastatic Castration-Resistant Prostate Cancer Between Local and Central Laboratories in Korea

BACKGROUND: Following success of the phase III PROfound trial, the poly (ADP-ribose) polymerase (PARP) inhibitor olaparib was approved by the US Food and Drug Administration in May 2020 for adult patients with deleterious homologous recombination repair (HRR) gene-mutated metastatic castration-resis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Yoonjung, Park, Inho, Kim, Boyeon, Choi, Yu Jeong, Oh, Seoung Chul, Lee, Kyung-A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Society for Laboratory Medicine 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9467836/ https://www.ncbi.nlm.nih.gov/pubmed/36045058 http://dx.doi.org/10.3343/alm.2023.43.1.64

Ejemplares similares

Impact of mutations in homologous recombination repair genes on treatment outcomes for metastatic castration resistant prostate cancer
por: Carlson, Alexander S., et al.
Publicado: (2020)

Detection of EGFR-SEPT14 fusion in cell-free DNA of a patient with advanced gastric cancer: A case report
por: Kim, Boyeon, et al.
Publicado: (2021)

Identification of Potential Genomic Alterations Using Pan-Cancer Cell-Free DNA Next-Generation Sequencing in Patients With Gastric Cancer
por: Kim, Boyeon, et al.
Publicado: (2024)

Multi-Gene Next-Generation Sequencing Panel for Analysis of BRCA1/BRCA2 and Homologous Recombination Repair Genes Alterations Metastatic Castration-Resistant Prostate Cancer
por: Maloberti, Thais, et al.
Publicado: (2023)

Genetic testing for homologous recombination repair (HRR) in metastatic castration-resistant prostate cancer (mCRPC): challenges and solutions
por: Scott, Rodney J., et al.
Publicado: (2021)

An optimized BRCA1/2 next-generation sequencing for different clinical sample types
por: Kim, Yoonjung, et al.
Publicado: (2019)

Homologous Recombination Repair Gene Mutation Characterization by Liquid Biopsy: A Phase II Trial of Olaparib and Abiraterone in Metastatic Castrate-Resistant Prostate Cancer
por: Carr, T. Hedley, et al.
Publicado: (2021)

De Novo Cancer Incidence after Kidney Transplantation in South Korea from 2002 to 2017
por: Kim, Boyeon, et al.
Publicado: (2021)

Preclinical patient‐derived modeling of castration‐resistant prostate cancer facilitates individualized assessment of homologous recombination repair deficient disease
por: Elsesy, Mohamed E., et al.
Publicado: (2023)

Selecting short length nucleic acids localized in exosomes improves plasma EGFR mutation detection in NSCLC patients
por: Kim, Yoonjung, et al.
Publicado: (2019)

Exploring the Impact of Treatment Switching on Overall Survival from the PROfound Study in Homologous Recombination Repair (HRR)-Mutated Metastatic Castration-Resistant Prostate Cancer (mCRPC)
por: Evans, Rachel, et al.
Publicado: (2021)

Next Generation Sequencing in metastatic castrate-resistant prostate cancer
por: Adashek, Jacob J., et al.
Publicado: (2018)

The prevalence of gene mutations in homologous recombination repair pathways in Japanese patients with metastatic castration‐resistant prostate cancer in real‐world clinical practice: The multi‐institutional observational ZENSHIN study
por: Uemura, Hiroji, et al.
Publicado: (2022)

Next-Generation Sequencing Reveals a Very Low Prevalence of Deleterious Mutations of Homologous Recombination Repair Genes and Homologous Recombination Deficiency in Ovarian Clear Cell Carcinoma
por: Liu, Hangqi, et al.
Publicado: (2022)

Hereditary cancer syndrome-associated pathogenic variants are common in patients with hematologic malignancies subsequent to primary solid cancer
por: Oh, Joowon, et al.
Publicado: (2021)

Practical considerations for optimising homologous recombination repair mutation testing in patients with metastatic prostate cancer
por: Gonzalez, David, et al.
Publicado: (2021)

Homologous Recombination Repair Polymorphisms and the Risk for Osteosarcoma
por: Goričar, Katja, et al.
Publicado: (2015)

Leveraging homologous recombination repair deficiency in sarcoma
por: Slade, Dea, et al.
Publicado: (2023)

Profiling cancer-associated genetic alterations and molecular classification of cancer in Korean gastric cancer patients
por: Kim, Yoonjung, et al.
Publicado: (2017)

Genome-wide Transcriptome Profiling of Homologous Recombination DNA Repair
por: Peng, Guang, et al.
Publicado: (2014)

CTCF cooperates with CtIP to drive homologous recombination repair of double-strand breaks
por: Hwang, Soon Young, et al.
Publicado: (2019)

Analysis of repair mechanism choice during homologous recombination
por: Agmon, Neta, et al.
Publicado: (2009)

DEK is required for homologous recombination repair of DNA breaks
por: Smith, Eric A., et al.
Publicado: (2017)

Homologous Recombination Repair Mechanisms in Serous Endometrial Cancer
por: Jönsson, Jenny-Maria, et al.
Publicado: (2021)

Homologous Recombination Repair Deficiency and Implications for Tumor Immunogenicity
por: van Wilpe, Sandra, et al.
Publicado: (2021)

A plant-specific module for homologous recombination repair
por: Wang, Xuanpeng, et al.
Publicado: (2022)

Selective utilization of non‐homologous end‐joining and homologous recombination for DNA repair during meiotic maturation in mouse oocytes
por: Lee, Crystal, et al.
Publicado: (2022)

HOXA10 is associated with temozolomide resistance through regulation of the homologous recombinant DNA repair pathway in glioblastoma cell lines
por: Kim, Jin Wook, et al.
Publicado: (2014)

DeviCNV: detection and visualization of exon-level copy number variants in targeted next-generation sequencing data
por: Kang, Yeeok, et al.
Publicado: (2018)

Impact of the COVID-19 Pandemic on Influenza Vaccination and Associated Factors among Pregnant Women: A Cross-Sectional Study in Korea
por: Kim, Boyeon, et al.
Publicado: (2023)

TOPORS-mediated RAD51 SUMOylation facilitates homologous recombination repair
por: Hariharasudhan, Gurusamy, et al.
Publicado: (2022)

Application of CRISPR/Cas9-based mutant enrichment technique to improve the clinical sensitivity of plasma EGFR testing in patients with non-small cell lung cancer
por: Kim, Boyeon, et al.
Publicado: (2022)

Next-generation androgen receptor inhibitors in non-metastatic castration-resistant prostate cancer
por: Lavaud, Pernelle, et al.
Publicado: (2020)

The prevalence and prognosis of next‐generation therapeutic targets in metastatic castration‐resistant prostate cancer
por: Pan, Jian, et al.
Publicado: (2022)

Pan-cancer Analysis of Tumor Mutational Burden and Homologous Recombination DNA Damage Repair Using Targeted Next-Generation Sequencing
por: Wang, Hai-Yun, et al.
Publicado: (2021)

RAD18 transmits DNA damage signaling to elicit homologous recombination repair
por: Huang, Jun, et al.
Publicado: (2009)

Prediction of urine culture results by automated urinalysis with digital flow morphology analysis
por: Kim, Dokyun, et al.
Publicado: (2021)

Clinical Impact of Somatic Variants in Homologous Recombination Repair-Related Genes in Ovarian High-Grade Serous Carcinoma
por: Choi, Min Chul, et al.
Publicado: (2020)

Repair of gaps opposite lesions by homologous recombination in mammalian cells
por: Adar, Sheera, et al.
Publicado: (2009)

REV1 and polymerase ζ facilitate homologous recombination repair
por: Sharma, Shilpy, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_9l7oqtscj5pfintd9sd49as4di